Workflow
Editas Medicine, Inc. (EDIT) Presents at Stifel 2023 Healthcare Conference (Transcript)
2023-11-14 22:15
Editas Medicine, Inc. (NASDAQ:EDIT) Stifel 2023 Healthcare Conference November 14, 2023 1:50 PM ET Company Participants Erick Lucera - EVP, CFO Cristi Barnett - VP, Corporate Communications and IR Conference Call Participants Dae Gon Ha - Stifel Dae Gon Ha Okay, let's go ahead and get started with the next session. Thanks everyone for joining us. For the next half hour or so, we're going to be talking Editas Medicine. My name is Dae Gon Ha, biotech analyst at Stifel. Joining me here on stage, we have Erick ...
Philip Morris International Inc. (PM) Chief Executives for Corporate Purpose CEO Investor Forum 2023 Transcript
2023-11-14 21:50
Philip Morris International Inc. (NYSE:PM) Chief Executives for Corporate Purpose CEO Investor Forum 2023 Call November 14, 2023 11:00 AM ET Company Participants Jacek Olczak - CEO and Chairman Conference Call Participants Unidentified Company Representative [Abrupt Start] …is really some of the most transformational efforts happening in business. Inevitably, when we send out invites to investors, both here and who are here in-person and those online, we'll hear from a few. I don't even want to hear from th ...
Vertex Pharmaceuticals Incorporated (VRTX) Jefferies Global Healthcare Conference Call Transcript
2023-11-14 21:44
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Jefferies Global Healthcare Conference Call November 14, 2023 3:30 AM ET Company Participants Stuart Arbuckle - Executive Vice President and Chief Operating Officer Conference Call Participants Michael Yee - Jefferies Michael Yee All right. Good morning, everybody. Thank you for joining us here on a beautiful morning session here at the Jefferies Global Healthcare Conference here in London. I'm Michael Yee, one of the senior biotechnology analyst here at Jef ...
EOG Resources, Inc. (EOG) BofA Securities Global Energy Conference (Transcript)
2023-11-14 21:07
EOG Resources, Inc. Conference Call Summary Company Overview - **Company**: EOG Resources, Inc. (NYSE:EOG) - **Event**: BofA Securities Global Energy Conference - **Date**: November 14, 2023 Key Industry Insights - **Oil and Gas Market Volatility**: EOG acknowledges the volatility in oil and gas prices, with oil prices recently dropping by $20 and gas prices fluctuating significantly. The company emphasizes the importance of being a low-cost operator to navigate these fluctuations effectively [3][4][6]. - **Long-term Outlook**: EOG maintains a bullish long-term view on both oil and natural gas, highlighting the necessity for continued investment in the sector despite the ongoing energy transition discussions [8][9]. Financial Metrics and Strategy - **Breakeven and Returns**: EOG operates with a premium price deck of $40 for oil and $2.50 for natural gas, aiming for a 30% direct after-tax rate of return. The company focuses on reducing breakeven costs and achieving margin expansion [5][46]. - **Investment Philosophy**: The company prioritizes high returns over growth, investing in projects that can consistently improve returns year over year [4][5]. Exploration and Development - **Gas Portfolio Shift**: EOG is pivoting towards gas development, particularly in the Dorado and Utica plays, while still focusing on oil due to better margins [7][10]. - **Dorado Play**: This natural gas play in South Texas is expected to be significant for North America's LNG future. EOG has invested in infrastructure to reduce transportation costs, enhancing competitiveness [12][14][15]. - **Utica Play**: EOG is revisiting the Utica with modern fracking technology, having previously explored it without success. The company is optimistic about the potential for improved recovery rates using new techniques [16][18][21]. Operational Efficiency - **Decentralized Operations**: EOG emphasizes a decentralized organizational structure, empowering local teams to make decisions based on real-time data, which enhances operational efficiency across its 16 plays in 9 basins [29][30]. - **Technology and Innovation**: Continuous improvement in completion designs and drilling techniques is a focus, with recent advancements leading to a 20% uplift in production rates in the Wolfcamp area [61][62]. M&A Considerations - **M&A Strategy**: EOG is cautious about pursuing M&A opportunities, preferring to focus on organic growth and exploration. The company evaluates potential acquisitions based on their ability to enhance existing returns rather than simply adding production [32][33][34]. Inventory and Future Outlook - **Resource Base**: EOG claims to have approximately 10 billion barrels of equivalent resources with a finding and development cost of less than $10 per BOE, providing a 30-year production outlook at current rates [47][48]. - **Double Premium Strategy**: The company has set a target of achieving a double premium return of 60% at the $40 oil and $2.50 natural gas price deck, reflecting a commitment to high-return projects [46][50]. Conclusion EOG Resources, Inc. is strategically positioned to navigate the volatile oil and gas market through a focus on low-cost operations, innovative technology, and a diversified portfolio. The company's commitment to organic growth and operational efficiency, combined with a cautious approach to M&A, underscores its long-term vision for sustainable returns in the energy sector.
CSX Corporation (CSX) Stephens Investment Conference Call Transcript
2023-11-14 20:27
CSX Corporation (NASDAQ:CSX) Stephens Investment Conference Conference Call November 14, 2023 10:00 AM ET Company Participants Sean Pelkey - EVP & CFO Matthew Korn - Head, IR Conference Call Participants Justin Long - Stephens Inc. Justin Long This is Justin Long with Stephens. I want to welcome everybody back to our Nashville conference in 2023. Next up, we have CSX, and representing the company, sitting to my right is Sean Pelkey, CFO. As a reminder, this will be a fireside chat format. I'll start with a ...
Automatic Data Processing, Inc. (ADP) TD Cowen Human Capital Management Summit Conference (Transcript)
2023-11-13 23:22
Automatic Data Processing, Inc. (NASDAQ:ADP) TD Cowen Human Capital Management Summit Conference Call November 13, 2023 12:00 PM ET Company Participants Jim Sperduto - President, Small Business Solutions Conference Call Participants Bryan Bergin - TD Cowen Jared Levine - TD Cowen Bryan Bergin Alright. Thank you. Good morning or good afternoon, and welcome to TD Cowen HCM Summit. I’m Bryan Bergin, I am joined by my colleague, Jared Levine. And we are very excited to have you and be with ADP. Really needs no ...
Novartis AG (NVS) 10th Annual ESG Investor Event Conference (Transcript)
2023-11-13 20:24
Novartis AG (NYSE:NVS) 10th Annual ESG Investor Event Conference November 13, 2023 10:30 AM ET Company Participants Maria Victoria Cuevas - IR Vas Narasimhan - CEO Lutz Hegemann - President, Global Health & Sustainability Thierry Diagana - Head, Global Health Research Sujata Vaidyanathan - Global Development Head Paul Penepent - Head Finance Reporting & Accounting Dr. Klaus Moosmayer - Chief Ethics, Risk & Compliance Officer Maria Victoria Cuevas Good morning and good afternoon. Thank you so much for joinin ...
Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript)
2023-11-13 14:55
Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event November 11, 2023 6:00 PM ET Company Participants Daniel Bohsen - Head of Investor Relations Martin Holst Lange - Executive Vice President, Development Robin Evers - Senior Vice President of Medical Affairs, Regulatory and Safety Conference Call Participants Richard Vosser - JPMorgan Chase & Co Emily Field - Barclays Michael Novod - Nordea Pete Verdult - Citi Seamus Fernandez - Guggenheim Securities Martin Parkhøi - SEB Pete Welford - Jefferies Michael ...
Bristol-Myers Squibb Company (BMY) Management Presents at 2023 UBS BioPharma Conference (Transcript)
2023-11-12 11:47
Bristol-Myers Squibb Company (NYSE:BMY) 2023 UBS BioPharma Conference Transcript November 8, 2023 8:00 AM ET Executives Lynelle Hoch - Head, Cell Therapy Analysts Trung Huynh - UBS Trung Huynh Okay. It’s 8 a.m. My name is Trung Huynh. I am one of the Therapeutics Analyst here at UBS. It’s my great pleasure to present to you guys, Bristol-Myers Squibb, for our first fireside session and conference. Today, we are talking about cell therapy for the next 45 minutes and for that we have got Lynelle Hoch, who is ...
Honeywell International Inc. (HON) Baird's Global Industrial Conference (Transcript)
2023-11-12 06:25
Honeywell International Inc. (NASDAQ:HON) Baird’s Global Industrial Conference Call November 7, 2023 8:20 AM ET Company Participants Jim Currier - President and Chief Executive Officer Conference Call Participants Peter Arment - Baird Peter Arment Thanks. Good morning, everyone. My name is Peter Arment. I’m the Senior Aerospace Defense Analyst here at Baird. I am delighted to have Jim Currier, who is the President and CEO of Honeywell Aerospace, 17-year veteran for Honeywell, has really covered all aspects ...